InvestorsHub Logo
Followers 40
Posts 4472
Boards Moderated 0
Alias Born 02/28/2018

Re: HoldWhatDoor post# 107341

Thursday, 03/03/2022 3:51:22 PM

Thursday, March 03, 2022 3:51:22 PM

Post# of 113774
BAAAAA HHAHA!!! I told the Bozoos here Month ago, Pegan Never left the Drug, His main part of the work was done, his lab moved but that obviously won't stop him from getting some credit in SBFM-PL4.

Pegan was joined in the research by several colleagues at the University of Georgia. Of these, David Crich led the compound synthesis team and served as co-designer of the compounds with Pegan; Ralph Tripp led the antiviral testing group; and Brian Cummings, now at Wayne State University, led the toxicology efforts.



Everybody got a role to play, its why they call it a Team.

I pretty much stop posting her because this bored is just way Sad for me.

All that matter is what the company has to say in the coming days. I waited a couple of years, what a few more days.

This stock will not drop, dream on.


Buy More $SBFM Its a Cancer and COVID Killer

But do Your Own DD

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News